Nearly one in four patients admitted to U.S. hospitals experience preventable harm. The Leapfrog Group (LFG), a national nonprofit organization driving a public health and policy movement in patient safety, engaged CURA Strategies to become their agency of record with the ultimate goal of increasing the public’s awareness of patient safety and the importance of hospital transparency to improve outcomes.

At the height of the opioid epidemic, medication-assisted treatment (MAT) was an undervalued tool, misunderstood by policymakers in Congress and at HHS. CURA Strategies designed and operationalized Advocates for Opioid Recovery (AOR) to help break down legislative, insurance, legal and regulatory barriers to evidence-based recovery from opioid use disorder.

With one in five Americans living with mental illness, the Kennedy Forum believed it was critical that mental health reform took prominence in policy discussions during the 2020 election season. The Kennedy Forum sought CURA’s support in building a movement that would bring mental health and addiction reform to the forefront of national policy talks.

Despite growing awareness of the opioid crisis, addiction and recovery remain highly stigmatized—

impacting those in recovery along with their support networks. Mobilize Recovery sought CURA’s support in launching a first-of-its-kind national service campaign that would break down stigma, build connections and showcase the power of the recovery community as changemakers through acts of volunteerism.

The American College of Cardiology (ACC) is one of the largest cardiovascular medical societies in the world with over 54,000 members.

ACC partnered with CURA to to raise its profile as the leading source for cutting-edge cardiovascular science while expanding its media footprint beyond traditional medical trade outlets.

Kyverna Therapeutics, a clinical-stage biopharmaceutical company focused on CAR T-cell therapy for autoimmune conditions, sought a partner to support their stakeholder engagement and clinical trial recruitment efforts. 

CURA partnered with Kyverna to engage leading patient influencers in the autoimmune space to increase awareness of CAR T-cell therapy and Kyverna’s work. This resulted in lasting partnerships and increased engagement among high-value patient communities.

An estimated 35,000 patients in the United States are born with a single ventricle — one of the most complex heart defects. Currently, there are no FDA-approved therapies available for this patient population. Mezzion is conducting a Phase 3 clinical trial to evaluate whether its treatment can preserve and extend cardiac function. CURA has partnered with Mezzion to elevate their presence in the congenital heart disease community to strengthen their credibility and accelerate trial recruitment.

The Diabetes Patient Advocacy Coalition and Diabetes Leadership Council unite patients, employers, policymakers and the broader diabetes community to influence policies that protect patients. Despite their meaningful work for the chronic disease community, recognition of their brand, leaders and initiatives remained low. 

DPAC and DLC partnered with CURA to curate and elevate their brands among policymakers and patients.

CURA helped CareDx, a leader in advanced transplant diagnostics, successfully push for the 2020 passage of a bill that languished for 16 years — the Comprehensive Immunosuppressive Drug Coverage For Kidney Transplant Patients Act.

After that success, CareDx engaged CURA to help communicate the value of their tests to payers, whose private coverage lagged behind that of Medicare. In 2023, a private Medicare contractor proposed severely restricting coverage. Developed without transplant community input, the policy created confusion and threatened patient access to critical tools across the entirety of Medicare.

As the largest private funder of polycystic kidney disease (PKD) research in the U.S., the PKD Foundation supports education, advocacy and awareness of PKD, a chronic, genetic condition that often leads to renal failure.

Over the last six years, CURA has worked with the PKD Foundation to implement a comprehensive advocacy strategy that connects and engages key stakeholders to promote a clear set of legislative priorities in Washington, D.C.